View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NSF International Adds Pharma Biotech Services to India Office

Global public health organisation NSF International is now offering pharma biotech consulting and training services from its office in Gurugram, India. The addition of these consulting and technical services is a response to demands of India’s growing pharmaceutical industry.

"We’ve been working with India’s pharmaceutical industry for several years, but our new pharma biotech office in Gurugram makes working with NSF International easier than ever before," said Maxine Fritz, executive vice-president of Pharma Biotech for NSF International.

"India is one of the world’s largest producers of generic pharmaceuticals and it is important for NSF International to be here so we can help our clients adapt to changing global regulatory requirements."

NSF International provides pharma biotech consulting, training and technical services to India’s pharmaceutical industry, including:

  • Consulting: authoritative consulting services that are respected by major pharma and biopharma companies and regulatory agencies around the world
  • Remediation: sound pragmatic advice on how to respond to adverse regulatory inspection findings and build a compliant pharmaceutical quality system to avoid future problems
  • Auditing: inspections to check for compliance with GMPs, GLP, GCP, PV and CLIA requirements
  • Regulatory guidance: regulatory strategies based on corporate objectives for new therapeutics, existing or new applications, and combination products, including assessment of applicability of unique programmes and US FDA approval pathways
  • Training and education: comprehensive training and education programmes designed to develop the knowledge and skills needed to meet the challenges of a global and complex pharmaceutical industry

Earlier this year, NSF International partnered with the Indian Drug Manufacturers’ Association (IDMA) to launch an advanced program in pharmaceutical quality management (APPQM) in Bangalore. The five-module education program is specifically designed for Indian pharmaceutical companies to improve the effectiveness of their quality systems. NSF International will host the first training session on 25-28 September 2017.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology